Live Older Patients updates

Live Older Patients news coverage of developments with the latest updates. Stay on top of latest Older Patients news stories and find out what just happened, what is going on with Older Patients. The latest real-time news updates and headlines on Older Patients
Magnetic Pulses Reprogram Immune Cells to Combat Cancer
What Does "accessibility And Inclusion" Actually Mean?
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Brittany Strides For Her Sister This September
Planning Boost Frees 1500 Bed Nights in Hawke's Bay
New Uniforms Mark Milestone for Canberra Health Shift
EOI Opens for New Aged Care, Assisted Living Sites
Amivantamab-Chemo Yields Best Survival in EGFR NSCLC
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Dr Tass Warns Peptide Enthusiasm Has Outpaced Evidence
Fatigue Often Missed as Liver Disease Signal
WA Health Excellence Awards 2026 Finalists Named
Parramatta Park Blooms: Iconic Flower Festival Begins
Community Conversations About Mental Health
KAIST, KIOM Unveil Wearable Microneedle For Pain Relief
International Migration 14 September
Justin Gooding's Journey From Discovery To Impact
Polluted Air Linked to Increased Glaucoma, Cataract Risk
AI Tool Speeds Sepsis Detection on World Sepsis Day
Specialist Fee Crackdown Must Target More Than Outliers
Specialist Doctor Fee Crackdown Must Go Beyond Extreme Outliers
PBS Adds First Biologic for Uncontrolled COPD
Yemen's Child Brides: Pregnant, Starving at 13
Smartphones May Screen for Cataracts, Eye Issues
KAIST, KIOM Create Wearable Pain-Relief Device
NSW Liberals Push Adult Time for Youth Crimes
4200km U.S. Trek Promotes Prostate Cancer Awareness
Works Start On North West Regional Hospital ED
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
NSW Sepsis Day Unveils New AI Tool for Faster Detection
NSW Nationals Push Adult Time for Youth Crime Law
Perception Test Predicts Laser Surgery Success
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Tarlatamab Dosing Shows Promise in Small Cell Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
Diagnostics Target Hit, Waitlists Drop 21%
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
Mayor Mamdani Speaks at NYC 9/11 Interfaith Service